EGFR expression and cell proliferation were not affected by glutamate when cells were exposed to DNQX, an AMPAR inhibitor, which suggests that EGFR expression downstream from AMPAR activation contributes to glioma progression [45]. Here, EGFR is linked to central nervous system cancer.